Chemomab Therapeutics (CMMB) Change in Accured Expenses (2019 - 2023)
Chemomab Therapeutics (CMMB) posted Change in Accured Expenses of -$1.2 million for FY2025, compared with -$1.89 million in FY2024.
Powered by 
Analysis
Chemomab Therapeutics (CMMB) Change in Accured Expenses (2019 - 2023) Analysis & Trends
Since FY2018, Chemomab Therapeutics has reported Change in Accured Expenses for 8 years.
- Annual Change in Accured Expenses has run from a low of -$1.89 million in FY2024 to a high of $2.82 million in FY2022 over five years.
- Business Quant data shows CMMB's Change in Accured Expenses at -$1.89 million in FY2024, $45,000 in FY2023 (-98.4%), $2.82 million in FY2022 and -$1.28 million in FY2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -251.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Chemomab Therapeutics | 10.28 Mn | 10.28 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 416,000.00 |
| Sep 30, 2023 | 504,000.00 |
| Jun 30, 2023 | -661,000.00 |
| Mar 31, 2023 | -214,000.00 |
| Dec 31, 2022 | 801,000.00 |
| Sep 30, 2022 | 865,000.00 |
| Jun 30, 2022 | 464,000.00 |
| Mar 31, 2022 | 693,000.00 |
| Dec 31, 2021 | -18,000.00 |
| Sep 30, 2021 | -268,000.00 |
| Jun 30, 2021 | -1.08 Mn |
| Mar 31, 2021 | 85,000.00 |
| Dec 31, 2020 | 261,000.00 |
| Sep 30, 2020 | 398,000.00 |
| Jun 30, 2020 | -49,000.00 |
| Mar 31, 2020 | -218,000.00 |
| Dec 31, 2019 | 922,000.00 |
| Sep 30, 2019 | -87,000.00 |
| Jun 30, 2019 | -314,000.00 |
| Mar 31, 2019 | -220,000.00 |
API Access
Chemomab Therapeutics Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=CMMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "CMMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=CMMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();